Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boulder/denver blog main
glaxosmithkline
4
×
life sciences
national blog main
4
×
new york blog main
san francisco blog main
san francisco top stories
4
×
biotech
boston blog main
boston top stories
boulder/denver top stories
crispr
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
national
national top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
celgene
clinical trials
digital health
eli lilly
fda
ge ventures
gene editing
gilead sciences
johnson & johnson
What
new
4
×
bio
roundup
crispr
remains
adds
allogene
analyzes
approval
biogen’s
biopharma
biopharmaceutical
cancer
ceo
companies
company
congress
congressional
convo
data
developing
devices
diversity
drug
drugs
earlier
electronic
executives
failures
feud
financing
group
gv
health
hot
immunotherapy
insights
investors
ipo
isn’t
Language
Current search:
glaxosmithkline
×
photo
×
" national blog main "
×
" san francisco top stories "
×
new
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO